Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Dicofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients. It is used to treat conditions such as osteoarthritis, tendinitis, bursitis, fibromyalgia, and neuralgia.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical gel formulation of Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2%. This unique compounded formulation is specifically designed to provide targeted relief from a range of musculoskeletal conditions, including muscle spasms, joint pain, and inflammation.
The combination of Diclofenac Sodium and Lidocaine in this formulation offers a potent analgesic effect, effectively reducing pain. The addition of Cyclobenzaprine HCl works to alleviate muscle spasms, further enhancing the therapeutic benefits of this formulation.
This Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% topical gel formulation is a semisolid preparation that is dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, allowing for targeted treatment or absorption of the active ingredients. The gel-like consistency ensures a smooth application process, making it user-friendly and convenient for patients.
It is crucial to adhere to the usage instructions provided by your healthcare provider when using this formulation. This will ensure optimal results and minimize the risk of any potential side effects. If you have any queries or concerns about this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
This compounded formulation of Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel is a semisolid preparation designed for targeted treatment of musculoskeletal pain, inflammation, and spasm. The gel is dispensed through a pump mechanism, allowing for easy and precise application on the skin. It is crucial to note that this formulation should not be used by individuals with known hypersensitivity to any of the components of the formulation, or by those with a history of gastrointestinal bleeding or ulceration.
When using this formulation, be aware that the simultaneous use of other topical medications, particularly those containing salicylates, may heighten the risk of adverse effects. Similarly, the concurrent use of other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), may increase the risk of gastrointestinal bleeding or ulceration.
Furthermore, this formulation should not be used by individuals with a history of cardiovascular disease, as the combination of lidocaine and cyclobenzaprine may increase the risk of adverse cardiovascular events. This formulation should also be avoided by those with a history of seizure disorders, as the combination of lidocaine and cyclobenzaprine may increase the risk of seizures.
Lastly, it is important to note that this formulation should not be used by pregnant or lactating women, as the safety of this formulation in these populations has not been established. If you have any questions about this formulation or its use, please do not hesitate to reach out for further information.
Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel is a compounded formulation that combines the therapeutic benefits of three potent medications. This unique blend is designed to alleviate pain and inflammation.
Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the production of certain chemicals in the body that trigger inflammation and pain. Lidocaine, a local anesthetic, provides pain relief by blocking nerve signals in the area where the gel is applied. Cyclobenzaprine HCl, a muscle relaxant, further enhances the formulation's efficacy by blocking nerve signals that cause muscle spasms and pain.
This topical gel is dispensed through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the active ingredients are absorbed directly into the skin at the site of pain or inflammation. This targeted treatment approach helps to maximize the therapeutic benefits while minimizing potential side effects.
It is crucial to use this medication as directed by your healthcare provider. Typically, the gel should be applied to the affected area two to four times daily, and rubbed in until completely absorbed. After application, hands should be washed thoroughly to avoid accidental contact with the eyes or other mucous membranes. This medication should not be used on broken or irritated skin, and prolonged use beyond 14 days should only be under the guidance of a healthcare professional.
If you have any questions or concerns about using Diclofenac Sodium 10%/Lidocaine 10%/Cyclobenzaprine HCl 2% Topical Gel, it is recommended to consult with your healthcare provider to ensure safe and appropriate use of this medication.
This is a compounded medication that combines three active ingredients: Diclofenac Sodium, Lidocaine, and Cyclobenzaprine HCl. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
This formulation is designed for targeted treatment or absorption of the active ingredients. It is typically used for pain relief and muscle relaxation.
Apply the gel to the affected area as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
The active ingredients are Diclofenac Sodium, Lidocaine, and Cyclobenzaprine HCl. Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID), Lidocaine is a local anesthetic, and Cyclobenzaprine HCl is a muscle relaxant.
The gel has a semisolid, gel-like consistency that allows it to be easily spread on the skin.
This gel is intended for external use only. Avoid contact with eyes, mouth, and other mucous membranes. Always use as directed by your healthcare provider.
If you experience any side effects such as skin irritation, redness, or swelling, stop using the product and contact your healthcare provider immediately.
Store the gel at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.
Before using this gel, inform your healthcare provider about any other medications you are currently taking to avoid potential drug interactions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
